176 related articles for article (PubMed ID: 21716132)
21. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
[TBL] [Abstract][Full Text] [Related]
22. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.
Chen CH; Lee CM; Hung CH; Wang JH; Hu TH; Changchien CS; Lu SN
J Gastroenterol Hepatol; 2011 Mar; 26(3):461-8. PubMed ID: 21332543
[TBL] [Abstract][Full Text] [Related]
24. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
Chen YC; Huang SF; Chu CM; Liaw YF
J Viral Hepat; 2012 Feb; 19(2):138-46. PubMed ID: 22239503
[TBL] [Abstract][Full Text] [Related]
25. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
26. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood.
Wu JF; Chiu YC; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH
Hepatology; 2016 Jan; 63(1):74-82. PubMed ID: 26389515
[TBL] [Abstract][Full Text] [Related]
27. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
Bzowej NH; Tran TT; Li R; Belle SH; Smith CI; Khalili M; Chung R; Tsai N; Terrault N;
Am J Gastroenterol; 2019 Aug; 114(8):1283-1291. PubMed ID: 31082876
[TBL] [Abstract][Full Text] [Related]
28. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis].
Li JQ; Zhuang H; Du H; Wang XH; Duan XZ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881
[TBL] [Abstract][Full Text] [Related]
30. HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
Colombatto P; Barbera C; Bortolotti F; Maina AM; Moriconi F; Cavallone D; Calvo P; Oliveri F; Bonino F; Brunetto MR
J Med Virol; 2018 Jul; 90(7):1232-1239. PubMed ID: 29488227
[TBL] [Abstract][Full Text] [Related]
31. Short-term lamivudine therapy in patients with chronic hepatitis B.
Chien RN; Liaw YF
Intervirology; 2003; 46(6):362-6. PubMed ID: 14688453
[TBL] [Abstract][Full Text] [Related]
32. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion.
Nie H; Evans AA; London WT; Block TM; Ren XD
J Hepatol; 2012 Apr; 56(4):795-802. PubMed ID: 22173170
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
34. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
35. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
36. Effect of menarche onset on the clinical course in females with chronic hepatitis B virus infection.
Wu JF; Tsai WY; Tung YC; Chen HL; Ni YH; Hsu HY; Chang MH
J Pediatr; 2014 Sep; 165(3):534-8. PubMed ID: 24973292
[TBL] [Abstract][Full Text] [Related]
37. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.
Buster EH; Hansen BE; Lau GK; Piratvisuth T; Zeuzem S; Steyerberg EW; Janssen HL
Gastroenterology; 2009 Dec; 137(6):2002-9. PubMed ID: 19737568
[TBL] [Abstract][Full Text] [Related]
38. Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.
Tseng TC; Liu CJ; Chen CL; Wang CC; Su TH; Kuo SF; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2012 Jan; 205(1):54-63. PubMed ID: 22095766
[TBL] [Abstract][Full Text] [Related]
39. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
[TBL] [Abstract][Full Text] [Related]
40. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
Chien RN; Liaw YF; Atkins M
Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
